F. Jensen

R. Moss, F. Jensen, D. Carlo, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Induction of lymphoma in athymic mice: a model for study of the human disease.

N. Kaplan, F. Jensen, G. Beattie, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Highly efficient induction of type C retroviruses by a human tumor in athymic mice.

N. Kaplan, F. Jensen, A. Knowles, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Karyotypic, virologic, and immunologic analyses of two continuous lymphocyte lines established from New Zealand black mice: possible relationship of chromosomal mosaicism to autoimmunity.

R. Lerner, S. Kennel, U. Francke, 1972, Proceedings of the National Academy of Sciences of the United States of America.

Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis

F. Jensen, E. Tan, H. Rabin, 1978, The Journal of experimental medicine.

Autoproliferation in HIV‐1‐infected patients undergoing active HIV‐1‐specific immunotherapy

F. Jensen, D. Carlo, R. Trauger, 1995, Clinical and experimental immunology.

Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography.

F. Jensen, D. Carlo, F. Ferré, 1998, Vaccine.

Polymorphism of the major envelope glycoprotein (gp70) of murine C-type viruses: virion associated and differentiation antigens encoded by a multi-gene family

R. Lerner, F. Jensen, J. Elder, 1977, Nature.

Effects of sv40 virus on the chromosomes of poikilothermic cells (Gekko gecko) cultivated at different temperatures

F. Jensen, M. Cohen, H. Clark, 1972, International journal of cancer.

Sv40‐induced transformation of cells of the lizard Gekko gecko

F. Jensen, V. Defendi, H. Clark, 1972, International journal of cancer.

Structural markers on core protein p30 of murine leukemia virus: functional correlation with Fv-1 tropism.

R. Lerner, F. Jensen, J. Elder, 1978, Proceedings of the National Academy of Sciences of the United States of America.

Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzees.

F. Jensen, D. Carlo, R. Peters, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Immunochemical delineation of an oncofetal antigen on normal and simian virus 40-transformed human fetal melanocytes.

F. Jensen, B. Giovanella, D. Galloway, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Structural diversity among retroviral gene products: a molecular approach to the study of biological function through structural variability.

R. Lerner, F. Jensen, J. Elder, 1981, Advances in cancer research.

Structural analysis of the major envelope glycoprotein (gp70) of the amphotropic and ecotropic type C viruses of wild mice.

B. K. Pal, R. Lerner, F. Jensen, 1978, Virology.

Production of Hormones by Human Anterior Pituitary Cells in Serial Culture

R. T. Price, F. Jensen, M. M. Vincent, 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Transformation of Human Cells by Oncogenic Virus SV40

F. Jensen, A. Girardi, 1966 .

Oncogenicity by DNA Tumor Viruses: Enhancement after Ultraviolet and Cobalt-60 Radiations

F. Jensen, V. Defendi, 1967, Science.

Absence of repressor in SV40-transformed cells.

F. Jensen, H. Koprowski, 1969, Virology.

Morphological and virological investigation of human tissue cultures transformed with SV40.

F. Jensen, J. Pontén, H. Koprowski, 1963, Journal of cellular and comparative physiology.

Induction of high serum levels of retroviral env gene products (gp70) in mice by bacterial lipopolysaccharide.

F. Jensen, S. Izui, J. Elder, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Differential expression of two distinct xenotropic viruses in NZB mice.

R. Lerner, F. Jensen, H. Morse, 1980, Clinical immunology and immunopathology.

Amplification of the murine leukemia virus Mr 70,000 glycoprotein gene product by human xenografts in athymic mice.

N. Kaplan, F. Jensen, G. Beattie, 1983, Cancer research.

Lipid composition and fluidity of the human immunodeficiency virus.

F. Jensen, P. Mobley, C. Curtain, 1988, Proceedings of the National Academy of Sciences of the United States of America.

IMMUNOPATHOGENICITY AND ONCOGENICITY OF MURINE LEUKEMIA VIRUSES I. Induction of Immunologic Disease and Lymphoma in (BALB/c x NZB)F1 Mice by Scripps Leukemia Virus*, $

F. Jensen, B. Croker, F. Dixon, 2003 .

Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants.

R. Lerner, F. Jensen, J. Elder, 1977, Proceedings of the National Academy of Sciences of the United States of America.

Autologous and Homologous Implantation of Human Cells Transformed In Vitro by Simian Virus 40

F. Jensen, J. Pontén, H. Koprowski, 1964 .

Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes.

F. Jensen, R. C. Aloia, R C Aloia, 1993, Proceedings of the National Academy of Sciences of the United States of America.

A SIMPLE ORGAN CULTURE METHOD WHICH ALLOWS SIMULTANEOUS ISOLATION OF SPECIFIC TYPES OF CELLS.

F. Jensen, J. Biggers, R. Gwatkin, 1964, Experimental cell research.

Transformation of African Green Monkey Kidney Cells by Irradiated Adenovirus 7-Simian Virus 40 Hybrid

F. Jensen, V. Defendi, 1968, Journal of virology.

Analysis of Some Viral Functions Related to Neoplastic Transformation

F. Jensen, V. Defendi, G. Sauer, 1967 .

RAPID TRANSFORMATION OF HUMAN FIBROBLAST CULTURES BY SIMIAN VIRUS.

F. Jensen, J. Pontén, H. Koprowski, 1963, Proceedings of the National Academy of Sciences of the United States of America.

Human serum lyses RNA tumour viruses

F. Jensen, N. Cooper, R. Welsh, 1975, Nature.

Lysis of oncornaviruses by human serum.

F. Jensen, N. Cooper, M. Oldstone, 1975, Bibliotheca haematologica.

Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway

F. Jensen, N. Cooper, M. Oldstone, 1976, The Journal of experimental medicine.

Nearest-neighbor interactions of the major RNA tumor virus glycoprotein on murine cell surfaces.

R. Lerner, F. Jensen, L. Takemoto, 1978, Proceedings of the National Academy of Sciences of the United States of America.

Induction of lymphoma in antigenically stimulated athymic mice.

N. Kaplan, F. Jensen, J. Lipsick, 1982, Cancer research.

Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.

G. Nemerow, F. Jensen, N. Cooper, 1982, The Journal of clinical investigation.

HIV-1-Specific Functional Immune Measurements as Markers of Disease Progression.

R. Moss, F. Jensen, D. Carlo, 1997, Journal of biomedical science.

Development and validation of a polymerase chain reaction method for the precise quantitation of HIV‐1 DNA in blood cells from subjects undergoing a 1‐year immunotherapeutic treatment

F. Jensen, D. Carlo, A. Daigle, 1993, AIDS.

Initial studies on active immunization of HIV-infected subjects using a gp120-depleted HIV-1 Immunogen: long-term follow-up.

F. Jensen, D. Carlo, S. Groshen, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Quantitation of HIV viral burden by PCR in HIV seropositive Navy personnel representing Walter Reed stages 1 to 6.

F. Jensen, D. Carlo, M. Wallace, 1992, AIDS research and human retroviruses.

Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome

R. B. Swenson, F. Jensen, P. Fultz, 1986, Journal of virology.

The effects of an HIV‐1 immunogen (Remune) on viral load, CD4 cell counts and HIV‐specific immunity in a double‐blind, randomized, adjuvant‐controlled subset study in HIV infected subjects regardless of concomitant antiviral drugs

F. Jensen, D. Carlo, C. Duffy, 2001, HIV medicine.

Specific Complement-Fixing Tumor Antigen in SV40-Trans formed Human Cells.∗

F. Jensen, H. Koprowski, J. Pagano, 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Pathogenesis of the slow disease of the central nervous system associated with wild mouse virus. III. Role of input virus and MCF recombinants in disease.

F. Jensen, M. Oldstone, J. Elder, 1983, Virology.

University of Southern Denmark A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC)

F. Jensen, F. Donskov, P. Geertsen, 2018 .

Induction of sarcomas in athymic mice.

N. Kaplan, F. Jensen, G. Beattie, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Thermotropic lipid phase separation in the human immunodeficiency virus.

F. Jensen, P. Mobley, C. Curtain, 1988, Biochimica et biophysica acta.

B‐tropic oncornavirus production by BALB/c methylcholanthrene‐induced sarcoma cells

F. Jensen, S. Russell, G. Gillespie, 1978, International journal of cancer.

Effect of HIV‐specific immune‐based therapy in subjects infected with HIV‐1 subtype E in Thailand

W. Sirawaraporn, R. Moss, F. Jensen, 1998, AIDS.

HIV-1-specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant.

R. Moss, F. Jensen, D. Carlo, 2000 .

T-Helper-Cell Proliferative Responses to Whole-Killed Human Immunodeficiency Virus Type 1 (HIV-1) and p24 Antigens of Different Clades in HIV-1-Infected Subjects Vaccinated with HIV-1 Immunogen (Remune)

R. Moss, F. Jensen, D. Carlo, 2000, Clinical Diagnostic Laboratory Immunology.

IgG and IgM antibodies to rubella quantitated by enzyme immunoassay.

F. Jensen, R. Nakamura, R. Johnson, 1982, Journal of immunoassay.

Maternal and newborn immunization with a human immunodeficiency virus‐1 immunogen in a rodent model

R. Moss, F. Jensen, D. Carlo, 2002, Immunology.

In vitro immune function after vaccination with an inactivated, gp120-depleted HIV-1 antigen with immunostimulatory oligodeoxynucleotides.

R. Moss, F. Jensen, D. Carlo, 2000, Vaccine.

In Vitro p24 Antigen-Stimulated Lymphocyte Proliferation and β-Chemokine Production in Human Immunodeficiency Virus Type 1 (HIV-1)-Seropositive Subjects after Immunization with an Inactivated gp120-Depleted HIV-1 Immunogen (Remune)

R. Moss, F. Jensen, D. Carlo, 1998, Clinical Diagnostic Laboratory Immunology.

Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on beta-chemokine and cytokine production in subjects with HIV-1 infection.

R. Moss, F. Jensen, D. Carlo, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind, adjuvant controlled trial.

R. Moss, F. Jensen, D. Carlo, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Expression of perforin on HIV‐1‐specific CD8+ lymphocytes after immunization with a gp120‐depleted, whole‐killed HIV‐1 immunogen

R. Moss, F. Jensen, D. Carlo, 2001, Clinical and experimental immunology.

The strategy of immunologic control of HIV-1 with structured treatment interruptions (STIs).

R. Moss, F. Jensen, D. Carlo, 2001, Current Drug Targets - Infectious Disorders.

Cell-mediated immune response to lymphocytic choriomeningitis and vaccinia virus in rats.

R. Zinkernagel, F. Jensen, A. Althage, 1977, Journal of immunology.

Inactivation and lysis of oncornaviruses by human and primate complement.

F. Jensen, 1979, Haematology and blood transfusion.

Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogen.

R. Moss, F. Jensen, D. Carlo, 1999, The Journal of infectious diseases.

HIV-Specific CD4(+) and CD8(+) immune responses are generated with a gp120-depleted, whole-killed HIV-1 immunogen with CpG immunostimulatory sequences of DNA.

R. Moss, F. Jensen, D. Carlo, 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Combination therapies against HIV-1 infection: exploring the concept of combining antiretroviral drug treatments with HIV-1 immune-based therapies in asymptomatic individuals.

R. Moss, F. Jensen, D. Carlo, 1996, AIDS patient care and STDs.

Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIY-1 Immunogen and antiviral drug therapy

R. Moss, F. Jensen, D. Carlo, 1996, Journal of Clinical Immunology.

Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogen

R. Moss, F. Jensen, D. Carlo, 2000, AIDS.

Rescue of infectious SV40 after fusion between dfferent SV 40-transformed cells.

F. Jensen, H. Koprowski, Z. Steplewski, 1968, Proceedings of the National Academy of Sciences of the United States of America.

The long-term maintenance of tumor explants.

F. Jensen, G. Castellano, 1960, Cancer chemotherapy reports.

Anti HTLV-III and Anti T-Cell Antibodies in AIDS and ARC Patients

D. Triglia, F. Jensen, H. Ioachim, 1985 .